The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
COVID-19 Threatens Pharma’s Global Supply Chain. What Next?
Webinar On Demand
In an increasingly global pharmaceutical supply chain, the COVID-19 outbreak has posed an existential challenge to an industry working across national borders. The virus has already shut down some production in China and affected exports of some active pharmaceutical ingredients from India. With access strained, cost inevitably increases.
A few key questions:
- How much of that cost can be passed along and how much must producers assume?
- Should the industry rewrite its supply chain script going forward?
- What policies should regulators have in hand to protect drug supplies for patients?
- Is it time for governments to subsidize API production in their own countries to insure constant supplies or can the market sort this out?
In this Fierce Pharma webcast, Leon Wyszkowski, President, Commercial Operations, and other experts discussed how to navigate the current global supply chain challenges.